financetom
Business
financetom
/
Business
/
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
May 3, 2024 6:41 AM

09:26 AM EDT, 05/03/2024 (MT Newswires) -- Telephone and Data Systems ( TDS/PV ) reported Q1 earnings Friday of $0.10 per diluted share, swinging from a loss of $0.08 a year earlier.

Two analysts polled by Capital IQ expected a loss of $0.12.

Operating revenue for the quarter ended March 31 was $1.26 billion, down from $1.30 billion a year earlier.

Two analysts surveyed by Capital IQ expected $1.26 billion.

For 2024, the company continues to expect service revenue of $2.95 billion to $3.05 billion from its United States Cellular (USM) unit and operating revenue of $1.07 billion to $1.10 billion from its TDS Telecom unit.

Shares of the company were up 1.5% in recent Friday premarket activity.

Price: 16.45, Change: +0.24, Percent Change: +1.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cresco Labs Secures Conditional Texas Medical Cannabis License
Cresco Labs Secures Conditional Texas Medical Cannabis License
Apr 2, 2026
03:57 PM EDT, 04/02/2026 (MT Newswires) -- Cresco Labs ( CRLBF ) said Thursday afternoon it was conditionally awarded a license under the Texas Compassionate Use Program, allowing it to cultivate, process, and dispense medical cannabis. The company said the license supports its state-by-state expansion strategy, with Texas being one of the largest markets in the United States. Winning a...
BRIEF-Spacex Targets More Than $2 Trillion Valuation In IPO - Bloomberg News
BRIEF-Spacex Targets More Than $2 Trillion Valuation In IPO - Bloomberg News
Apr 2, 2026
April 2 (Reuters) - * SPACEX TARGETS MORE THAN $2 TRILLION VALUATION IN IPO - BLOOMBERG NEWS Source text: https://tinyurl.com/24kuseh2 ...
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Apr 2, 2026
– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth – ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Esperion (the Company) today announced the closing of its acquisition of Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for...
NFI Group Appoints Rob Marion as President of Motor Coach Industries
NFI Group Appoints Rob Marion as President of Motor Coach Industries
Apr 2, 2026
03:55 PM EDT, 04/02/2026 (MT Newswires) -- NFI Group ( NFYEF ) on said Rob Marion will serve as president of the company's Motor Coach Industries (MCI) unit. The bus and coach manufacturer said Marion will start his new role immediately, reporting directly to NFI's chief executive, John Sapp. NFI's former CEO, Paul Soubry, had served as interim president of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved